Scout Investments, Inc. Pacira Bio Sciences, Inc. Transaction History

Scout Investments, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$25.5 - $31.51 $306,255 - $378,435	-12,010 Reduced 8.73%	125,571 $3.59 Million
Q1 2024 May 09, 2024	SELL	$27.7 - $35.48 $242,762 - $310,946	-8,764 Reduced 5.99%	137,581 $4.02 Million
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $60,509 - $78,878	-2,299 Reduced 1.55%	146,345 $4.94 Million
Q3 2023 Nov 09, 2023	SELL	$30.68 - $40.09 $132,568 - $173,228	-4,321 Reduced 2.82%	148,644 $4.56 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $164,273 - $216,030	-4,548 Reduced 2.89%	152,965 $6.13 Million
Q1 2023 May 11, 2023	BUY	$35.53 - $43.38 $319,237 - $389,769	8,985 Added 6.05%	157,513 $6.43 Million
Q4 2022 Jan 23, 2023	SELL	$38.19 - $57.45 $94,291 - $141,844	-2,469 Reduced 1.64%	148,528 $0
Q3 2022 Oct 18, 2022	BUY	$51.24 - $58.89 $308,516 - $354,576	6,021 Added 4.15%	150,997 $8.03 Million
Q2 2022 Jul 15, 2022	BUY	$51.49 - $81.64 $739,602 - $1.17 Million	14,364 Added 11.0%	144,976 $8.45 Million
Q1 2022 Apr 14, 2022	SELL	$60.03 - $76.49 $10,385 - $13,232	-173 Reduced 0.13%	130,612 $9.97 Million
Q4 2021 Jan 14, 2022	SELL	$47.97 - $62.21 $141,559 - $183,581	-2,951 Reduced 2.21%	130,785 $7.87 Million
Q3 2021 Oct 13, 2021	BUY	$54.64 - $61.3 $137,364 - $154,108	2,514 Added 1.92%	133,736 $7.49 Million
Q2 2021 Jul 23, 2021	BUY	$59.18 - $69.99 $975,759 - $1.15 Million	16,488 Added 14.37%	131,222 $7.96 Million
Q1 2021 Apr 09, 2021	BUY	$59.31 - $78.82 $6.8 Million - $9.04 Million	114,734 New	114,734 $8.04 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.